Additional Study Information: The purpose of this study is to look at a new treatment for non-muscle-invasive bladder cancer. This new form of paclitaxel, a drug currently used by injection into a vein to treat various types of cancer, is designed to be instilled (injected) into the urinary bladder with a catheter (tube) placed into your bladder through your urethra (the opening where your urine comes out), which is about a five-minute office procedure. The catheter is then removed and you are observed in the office for 2 hours. This is an investigational product, which means that it is not approved for bladder injection by the Food and Drug Administration (FDA).